Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revive Therapeutics Ltd (OP:RVVTF)

0.0151 -0.0010 (-6.21%)
Streaming Delayed Price Updated: 3:29 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revive Therapeutics Ltd

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Seelos Therapeutics (NASDAQ:SEEL) shares closed up 9.47% at $0.72 
Via Benzinga
Revive Therapeutics Moves On Step Closer In COVID Trial By Submitting Data Access Plan To The FDA
It was an expected step, but a notable one nonetheless. Revive Therapeutics Ltd.(OTC: RVVTF) revealed they have submitted their Data Access Plan to the U.S. Food & Drug Administration (FDA). 
Via Benzinga
ATAI Life Sciences, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 3.55% at $0.36 
Via Benzinga
Psychedelic Stock Gainers And Losers From June 3, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 5.88% at $0.35 
Via Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 9.50% at $0.75 
Via Benzinga
ATAI Life Sciences, Intelgenx Technologies Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 7.05% at $0.91 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 31, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 8.54% at $0.36 
Via Benzinga
Revive Therapeutics: Positive Comments From The FDA Regarding Primary Endpoint Change
The outlook for Revive Therapeutics Ltd. (OTC: RVVTF) Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19 got a little brighter on Thursday. 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 26, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.06% at $0.34 
Via Benzinga
TripAdvisor, Seelos Therapeutics Among Top Psychedelic Movers Of Today
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 6.06% at $23.45 
Via Benzinga
Psyched: Medical Psychedelics In Davos, Canadian Sen Does Psychedelics, Ei.Ventures & Mycotopia To Merge Into $383M Company
Medical Psychedelics have made it into Davos, just in time for the World Economic Forum. 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 24, 2022
GAINERS: LOSERS: Cybin (AMEX:CYBN) shares closed down 9.99% at $0.61 
Via Benzinga
Cybin, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 15.60% at $0.68 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 20, 2022
GAINERS: Mind Medicine (NASDAQ:MNMD) shares closed up 8.33% at $0.77 
Via Benzinga
Revive Therapeutics, Allied Among Top Psychedelic Movers Of Today
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 21.90% at $0.29 
Via Benzinga
Upcoming U.S. FDA Decision A Potentially Major De-Risk Event For Revive Therapeutics
It’s been a long and arduous road for Revive Therapeutics Ltd. (OTC: RVVTF) regarding their Phase 3 clinical trial to evaluate the safety and efficacy of Bucillamine to treat COVID-19. 
Via Benzinga
Cybin, Allied Among Top Psychedelic Movers Of Today
GAINERS: Cybin (AMEX:CYBN) shares closed up 13.43% at $0.55 
Via Benzinga
Intelgenx Technologies, Cybin Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.85% at $0.32 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 16, 2022
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 25.00% at $0.22 
Via Benzinga
Field Trip Health, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 20.93% at $0.94 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 12, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.44% at $7.06 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 11, 2022
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 1.37% at $0.27 LOSERS: 
Via Benzinga
Intelgenx Technologies, Compass Pathways Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 16.68% at $0.26 
Via Benzinga
Psychedelic Stock Gainers And Losers From May 9, 2022
GAINERS: LOSERS: ATAI Life Sciences (NASDAQ:ATAI) shares closed down 13.47% at $3.34 
Via Benzinga
TripAdvisor, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 9.40% at $0.16 
Via Benzinga
GH Research, Intelgenx Technologies Among Top Psychedelic Movers Of Today
GAINERS: TripAdvisor (NASDAQ:TRIP) shares closed up 5.09% at $25.80 LOSERS: 
Via Benzinga
Intelgenx Technologies, Field Trip Health Among Top Psychedelic Movers Of Today
GAINERS: Intelgenx Technologies (OTC:IGXT) shares closed up 13.21% at $0.30 
Via Benzinga
Allied, ATAI Life Sciences Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 5.27% at $0.76 
Via Benzinga
Psyched: Elon Musk Praises Psychedelics Over Antidepressants, Field Trip To Split In Two, Colorado MDMA Bill Moves Forward
The world’s richest man gave another public nod to psychedelics medicine in favor of traditional mental health solutions. 
Via Benzinga
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 8.17% at $9.80 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.